Ulf Hannelius
Vermögen: 49 548 $ am 31.08.2026
Vermögen: 49 548 $ am 31.08.2026
Ulf Hannelius is currently Chairman at Diamyd Biomanufacturing AB and Director at Mainly AB since 2021.
Formerly, Dr. Hannelius was President & Chief Executive Officer at Diamyd Medical AB from 2016 to 2026.
Education includes a doctorate from Karolinska Institutet and an MBA from Stockholm School of Economics.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.08.2025 | 463.973 ( 0,31 % ) | 49 548 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Mainly AB
Mainly AB Packaged SoftwareTechnology Services Develops an AI research engineer platform | Direktor/Vorstandsmitglied | 22.02.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| DIAMYD MEDICAL AB | Vorstandsvorsitzender | 22.04.2026 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stockholm School of Economics
Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Diamyd Medical AB
Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes | Health Technology |
Mainly AB
Mainly AB Packaged SoftwareTechnology Services Develops an AI research engineer platform | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen